North America Artificial Intelligence (AI) in Healthcare Market (2025-2030)
The North America Artificial Intelligence (AI) in Healthcare Market was valued at $21.63 Million in 2025 and projected to reach to $110.61 Million by 2030, representing a compound annual growth rate of 38.6%. North America's AI in Healthcare market is poised for exceptional growth, expanding from $21.63 billion in 2025 to $110.61 billion by 2030 at a 38.6% CAGR.
North America Artificial Intelligence (AI) in Healthcare Market Trends and Insights
- In 2025, the North America AI in Healthcare market is estimated at $21.63 billion, reflecting strong momentum across diagnostic imaging, drug discovery, and clinical decision support systems.
- By 2030, North America is projected to reach $110.61 billion, representing a compound annual growth rate of 38.6%, underscoring the region's commitment to digital transformation and precision medicine. The expansion of North America's AI healthcare market is fueled by increasing demand for operational efficiency, rising healthcare costs, and growing adoption of machine learning algorithms in patient care.
- North America's leading healthcare institutions and technology companies are accelerating AI deployment across electronic health records, predictive analytics, and personalized treatment planning.
- The region's mature venture capital ecosystem and favorable reimbursement policies position North America as a critical growth engine for the global AI in Healthcare sector through 2030..
Key Market Statistics
- CAGR (2025-2030) 38.6% CAGR
- Market Size, 2025 ~USD 21.63 Million
- Forecast, 2030 ~USD 110.61 Million
- Geography North America
North America Artificial Intelligence (AI) in Healthcare Market Overview
Market Leadership Position :
North America commands the largest share of the global AI in Healthcare market, with the US alone representing $43.3 billion in 2030 forecasts, driven by early adoption of advanced diagnostic and clinical decision support technologies.
Robust R&D Investment Ecosystem :
The region benefits from substantial venture capital funding, government research grants, and partnerships between leading healthcare institutions and technology companies, accelerating AI innovation in medical imaging and drug discovery.
Regulatory Framework Advantage :
FDA approval pathways and established regulatory guidelines in the US and Canada provide clear commercialization routes for AI-powered medical devices and software, reducing time-to-market for innovative solutions.
High Healthcare Spending :
North America's elevated healthcare expenditure and digital infrastructure maturity enable rapid deployment of AI solutions across hospitals, clinics, and research institutions, supporting the 38.6% CAGR through 2030.
North America Artificial Intelligence (AI) in Healthcare Market Dynamics
- This expansion is fueled by increasing adoption of machine learning algorithms in diagnostic imaging, personalized medicine, and administrative automation across US and Canadian healthcare systems.
- The region's technological infrastructure, coupled with significant investment in AI startups and established healthcare IT vendors, creates a competitive landscape driving continuous innovation. Key growth drivers include rising demand for operational efficiency, labor shortage mitigation, and improved patient outcomes through predictive analytics.
- Regulatory clarity from the FDA and Health Canada supports market confidence, while partnerships between academic medical centers and technology firms accelerate real-world implementation.
- North America is expected to maintain its dominant market position, with the US representing the largest revenue contributor throughout the forecast period..
Related Ecosystem
Diagnostic Imaging
- Magnetic Resonance Imaging (MRI)
- Computed Tomography (CT)
- CT Scanners
- Nuclear Imaging
- Positron Emission Tomography
- Siemens healthineers
- PHILIPS HEALTHCARE
- CANON INC.
- FUJIFILM Holdings Corporation
- UNITED IMAGING HEALTHCARE CO., LTD.
Healthcare Analytics
- Machine Learning
- Natural Language Processing (NLP)
- Blood Pressure Monitors
- Computed Tomography (CT)
- Magnetic Resonance Imaging (MRI)
- Oracle Corporation
- PHILIPS HEALTHCARE
- Siemens healthineers
- Zensar Technologies Limited
- EPIC SYSTEMS CORPORATION
Healthcare It
- Computed Tomography (CT)
- Machine Learning
- Magnetic Resonance Imaging (MRI)
- Natural Language Processing (NLP)
- Predictive Analytics
- CERNER CORPORATION
- PHILIPS HEALTHCARE
- Oracle Corporation
- GE HealthCare Technologies Inc.
- Siemens healthineers
Key Takeaways
- North America's AI in Healthcare market is valued at $21.63 billion in 2025 and is expected to grow to $110.61 billion by 2030, driven by a 38.6% CAGR.
- North America leads in AI adoption due to advanced healthcare infrastructure, significant R&D spending, and supportive regulatory environments.
- North America's market growth is accelerated by rising healthcare costs, demand for operational efficiency, and widespread machine learning integration in clinical workflows.
- North America's robust venture capital ecosystem and favorable reimbursement policies position the region as a global leader in AI healthcare innovation through 2030.
Artificial Intelligence (AI) in Healthcare Market Report Scope
| Report Metric | Details |
|---|---|
| Base Year | 2025 |
| Forecast Period | 2025–2039 |
| Growth Rate | CAGR of 38.6% from 2025 to 2039 |
| Market Size Base Year (Billions) | ~USD 21.63 (2025) |
| Revenue Forecast (Billions) | ~USD 110.61 (2039) |
| Segments Covered | Offering, Function, Type, Technology, Application, Modality, Deployment Model, Tool, End User |
North America Artificial Intelligence (AI) in Healthcare Market Report Segmentation
9 segment dimensions are covered across the global market.
By Offering
- AI Technologies
- Integrated Solutions
- Niche/Point Solutions
- Services
By Function
- Administrative
- Data Management & Analytics
- Diagnosis & Early Detection
- Patient Engagement & Remote Monitoring
- Pharmacy Management
- Post-Treatment Surveillance & Survivorship Care
- Treatment Planning & Personalization
By Type
- Ambulatory Care Centers
- Asset Management
- Auto Coding
- Behavioral Therapy & Psychotherapy
- Billing & Claims Management
- Classification & Categorization
- Compliance & Documentation
- Convolutional Neural Networks (Cnn)
- Customer Relationship Management
- Cybersecurity
- Deep Learning
- Device Context
- Diagnostic & Imaging Centers
- Diagnostic Imaging
- Diagnostics Imaging
- Dosing & Administration
- Drug Allergy Alerting
- Drug Response Prediction
- Eprescribing
- Follow-Up & Long-Term Support
- Fraud Detection & Risk Management
- Generative Adversarial Networks (Gan)
- Graph Neural Networks (Gnn)
- Healthcare Assistance Robots
- Healthcare Workflow Management
- Home Healthcare Agencies & Assisted Living Facilities
- Hospitals & Clinics
- Immunotherapy
- Intraoperative Guidance & Robotics
- Ivd
- Long-Term Outcome Prediction
- Medication Management
- Medication Reminders
- Mental Health & Support Systems
- Motion Synchronization & Auto Contouring
- Other Administrative Functions
- Other Deep Learning Tools
- Other Diagnosis & Early Detection Functions
- Other Healthcare Providers
- Other Machine Learning Tools
- Other ML Tools
- Other Patient Engagement & Remote Monitoring Functions
- Other Pharmacological Therapy Functions
- Other Pharmacy Management Functions
- Other Radiation Therapy Functions
- Other Treatment Planning & Personalization Functions
- Patient Education & Empowerment
- Patient Eligibility & Authorization
- Patient Registration & Scheduling
- Pattern & Image Recognition
- Personalized Treatment Planning
- Pharmacies
- Pharmacological Therapy
- Pharmacy Audit & Analysis
- Physical Context
- Postoperative Analysis & Recovery
- Pre-Screening
- Precision Medicine & Genomic Analysis
- Predictive Models For Treatment Response
- Preoperative Imaging & 3D Modeling
- Private Payers
- Progress Monitoring & Feedback
- Public Payers
- Radiation Therapy
- Real-Time Adaptive Treatment Delivery
- Real-Time Patient Data Monitoring
- Recurrence Monitoring
- Recurrent Neural Networks (Rnn)
- Reinforcement Learning
- Relapse Prediction & Long-Term Management
- Response & Side-Effect Prediction
- Response Assessment & Quality Assurance
- Risk Assessment & Patient Stratification
- Sentiment Analysis
- Speech Recognition
- Supervised Learning
- Supply Chain & Inventory Management
- Surgical Therapy
- Symptom Management & Virtual Assistance
- Telehealth & Remote Patient Monitoring
- Text Analytics
- Treatment Recommendation Systems
- Unsupervised Learning
- User Context
- Virtual Counseling & Chatbots
- Workforce Management
By Technology
- Clinical Chemistry
- Immunoassays
- Molecular Diagnostics
By Application
- Biomarker Discovery & Analysis
- Clinical Applications
- Disease Interpretation & Report Analysis
- Image Analysis & Interpretation
- Image Captioning & Annotation
- Image Reconstruction
- Non-Clinical Applications
- Other Diagnostic Imaging Applications
- Other Ivd Applications
By Modality
- Computed Tomography (Ct)
- Magnetic Resonance Imaging (Mri)
- Nuclear Imaging (Pet & Spect)
- Other Diagnostic Imaging Modalities
- Ultrasound
- X-Ray Imaging
By Deployment Model
- Cloud-Based Models
- Hybrid Models
- On-Premise Models
By Tool
- Computer Vision
- Context-Aware Computing
- Generative AI
- Image Analysis
- Machine Learning (ML)
- Natural Language Processing (Nlp)
By End User
- Healthcare Payers
- Healthcare Providers
- Other End Users
- Patients
Target Audience
- Healthcare IT Vendors & Software Companies : Need North America market data to develop AI-powered solutions, plan product launches, and identify partnership opportunities with hospitals and health systems in the US and Canada.
- Medical Device Manufacturers : Require insights into diagnostic imaging and clinical decision support adoption rates to guide R&D investment, regulatory strategy, and commercialization timelines in North America's high-value market.
- Healthcare Providers & Hospital Systems : Seek market intelligence on AI implementation trends, vendor benchmarking, and ROI metrics to inform procurement decisions and digital transformation strategies across North American healthcare networks.
- Investment & Private Equity Firms : Need comprehensive market sizing and growth forecasts for North America to evaluate AI healthcare startups, identify acquisition targets, and allocate capital to high-potential companies in the region.
- Pharmaceutical & Biotech Companies : Require data on AI adoption in drug discovery and clinical trials within North America to optimize R&D efficiency, accelerate time-to-market, and justify investment in AI-driven research platforms.
Key Companies in the North America Artificial Intelligence (AI) in Healthcare Market
| Company | HQ | Ownership | Strongest segments |
|---|---|---|---|
| EPAM SYSTEMS, INC. | United States | ||
| SIEMENS AG | Germany | ||
| WNS GLOBAL SERVICES | India | ||
| L&T TECHNOLOGY SERVICES LIMITED | India | ||
| LARSEN & TOUBRO INFOTECH LIMITED | India | ||
| SOPRA STERIA | United States | ||
| CYIENT | India |
EPAM SYSTEMS, INC.
EPAM Systems, Inc. is a leading digital transformation and software engineering services company headquartered in the United States. The company provides consulting, software development, and IT services to clients across various industries globally.
SIEMENS AG
Siemens AG is a German multinational conglomerate providing automation, digitalization, and electrification solutions across industrial, infrastructure, and mobility sectors worldwide.
WNS GLOBAL SERVICES
WNS Global Services is an India-based business process management and IT services company offering customer engagement, finance and accounting, and technology solutions to global enterprises.
L&T TECHNOLOGY SERVICES LIMITED
L&T Technology Services Limited is an India-based engineering and technology services company providing design, engineering, and digital transformation solutions across multiple industries.
LARSEN & TOUBRO INFOTECH LIMITED
Larsen & Toubro Infotech Limited is an India-based IT services and consulting company offering digital transformation, cloud, and enterprise solutions to global clients.
SOPRA STERIA
Sopra Steria is a digital services and software company providing consulting, systems integration, and software development services, with operations in the United States and globally.
CYIENT
Cyient is an India-based engineering and technology services company specializing in digital, engineering, and cloud solutions for aerospace, defense, and industrial sectors.
Countries within North America - compare and drill down
| Country | 2025 size (native) |
|---|---|
| US | USD 43296.6 Million |
| Canada | USD 2396.8 Million |
Country market size visualization
Reasons to Buy this Report
- Market Size & Growth Validation : Comprehensive data on North America's $21.63B market (2025) and $110.61B forecast (2030) validates investment decisions and strategic planning for healthcare AI initiatives across the US and Canada.
- Country-Level Granularity : Detailed market segmentation for the US ($43.3B) and Canada ($2.4B) enables targeted go-to-market strategies and resource allocation based on regional market dynamics and competitive intensity.
- Regulatory & Reimbursement Insights : Understanding North America's FDA approval pathways, reimbursement models, and healthcare policy frameworks is critical for product commercialization and market entry planning in this highly regulated region.
- Competitive Landscape Intelligence : Identify key players, emerging startups, and partnership opportunities within North America's robust AI healthcare ecosystem to inform competitive positioning and M&A strategies.
- Application-Specific Opportunities : Detailed analysis of high-growth segments—diagnostic imaging, drug discovery, and clinical decision support—reveals specific investment and partnership opportunities aligned with North American healthcare priorities.
Frequently asked questions
What is the current market size of AI in Healthcare in North America?
North America's AI in Healthcare market is estimated at $21.63 billion in 2025, with projections to reach $110.61 billion by 2030.
What is the expected growth rate for North America's AI Healthcare market?
North America's AI in Healthcare market is expected to grow at a compound annual growth rate (CAGR) of 38.6% from 2025 to 2030.
What are the primary drivers of AI adoption in North America's healthcare sector?
North America's AI healthcare growth is driven by rising healthcare costs, demand for operational efficiency, advanced infrastructure, substantial R&D investment, and widespread adoption of machine learning in clinical decision support and diagnostic imaging.
Which applications of AI are most prevalent in North America's healthcare market?
North America's healthcare sector is leveraging AI across diagnostic imaging, drug discovery, clinical decision support systems, electronic health records optimization, predictive analytics, and personalized treatment planning.
What factors make North America a leader in AI healthcare innovation?
North America's leadership in AI healthcare is supported by advanced healthcare infrastructure, mature venture capital ecosystem, favorable reimbursement policies, strong regulatory frameworks, and significant investment from leading healthcare institutions and technology companies.
RESEARCH METHODOLOGY
The study involved significant efforts to estimate the current size of the artificial intelligence (AI) in healthcare market. Exhaustive secondary research was conducted to collect information on the artificial intelligence (AI) in healthcare market. The next step was to validate these findings, assumptions, and sizing estimates with industry experts across the value chain using primary research. Different approaches, such as top-down and bottom-up, were employed to estimate the total market size. After that, the market breakup and data triangulation procedures were used to estimate the market size of the segments and subsegments of the artificial intelligence (AI) in healthcare market.
Secondary Research
This research study involved the extensive use of secondary sources, directories, and databases such as Dun & Bradstreet, Bloomberg Businessweek, and Factiva; white papers, annual reports, and Companies House documents; investor presentations; and companies' SEC filings. The market for companies offering artificial intelligence (AI) in healthcare solutions is derived from secondary data available through paid and unpaid sources, analysis of the product portfolios of major companies in the ecosystem, and ratings of companies based on performance and quality. Various sources were consulted during the secondary research process to identify and collect information for this study. The secondary sources include annual reports, press releases, company investor presentations, white papers, journals, certified publications, articles by recognized authors, directories, and databases.
Various secondary sources were consulted during the secondary research process to identify and collect information relevant to the study. These sources included annual reports, press releases, investor presentations of artificial intelligence (AI) in healthcare vendors, forums, certified publications, and whitepapers. Secondary research was used to obtain critical information on the industry’s value chain, the pool of key players, market classification, and segmentation from market- and technology-oriented perspectives.
Primary Research
In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. Primary sources are mainly industry experts from the core and related industries, as well as preferred suppliers, manufacturers, distributors, technology developers, researchers, and organizations across all segments of this industry’s value chain. In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, among other experts, to obtain and verify critical qualitative and quantitative information and to assess prospects.
Primary research was conducted to identify segmentation types, key players, and key market dynamics, including drivers, restraints, opportunities, challenges, and strategies adopted by key players.
After the complete market engineering (calculations for market statistics, market breakdown, market size estimates, market forecasting, and data triangulation), extensive primary research was conducted to gather information and verify and validate the critical numbers derived.
In the complete market engineering process, top-down and bottom-up approaches, along with several data triangulation methods, were extensively used to perform market estimation and forecasting across the overall market segments and subsegments listed in this report. Extensive qualitative and quantitative analyses were conducted on the complete market engineering process to identify key information/insights throughout the report.
Note 1: Other designations include sales, marketing, and product managers.
Note 2: Tiers are defined based on a company’s total revenue. As of 2025: Tier 1 = >USD 1 billion, Tier 2 = USD 500 million to USD 1 billion, and Tier 3 = <USD 500 million.
To know about the assumptions considered for the study, download the pdf brochure
Market Size Estimation
The market size estimates and forecasts provided in this study are derived through a mix of the bottom-up approach (revenue share analysis of leading players) and top-down approach (assessment of utilization/adoption/penetration trends, by offering, function, application, deployment, tool, end user, and region).
Data Triangulation
After arriving at the overall market size—using the market size estimation processes—the market was split into several segments and subsegments. To complete the overall market engineering process and obtain the exact statistics for each market segment and subsegment, data triangulation and market breakdown procedures were employed wherever applicable. The data was triangulated by examining various factors and trends on both the demand and supply sides of the artificial intelligence (AI) in healthcare market.
Market Definition
The artificial intelligence (AI) in healthcare market encompasses the application of AI technologies, such as machine learning, natural language processing, computer vision, and robotics, to improve healthcare delivery, enhance operational efficiency, and provide personalized care. These solutions address a wide range of use cases, including diagnostic imaging, predictive analytics, drug discovery, patient engagement, remote monitoring, and administrative workflows, enabling healthcare providers, payers, and pharmaceutical companies to drive innovation and improve outcomes.
Key Stakeholders
- Artificial intelligence (AI) in healthcare software vendors
- Artificial intelligence (AI) in healthcare service providers
- Independent software vendors (ISVs)
- Platform providers
- Technology providers
- System integrators
- Cloud service providers
- Healthcare IT service providers
- Hospitals and surgical centers
- Diagnostic imaging centers
- Academic institutes and research laboratories
- Forums, alliances, and associations
- Government organizations
- Institutional investors and investment banks
- Investors/Shareholders
- Venture capitalists
- Research and consulting firms
Report Objectives
- To define, describe, and forecast the global artificial intelligence (AI) in healthcare market based on offering, function, application, deployment, tool, end user, and region
- To provide detailed information regarding the factors influencing the growth of the market (such as the drivers, restraints, opportunities, and challenges)
- To strategically analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall artificial intelligence (AI) in healthcare market
- To analyze market opportunities for stakeholders and provide details of the competitive landscape for market leaders
- To forecast the size of the artificial intelligence (AI) in healthcare market in five main regions (along with their respective key countries): North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa
- To profile key players and comprehensively analyze their product portfolios, market positions, and core competencies in the market
- To track and analyze competitive developments such as product & service launches; expansions; partnerships, agreements, and collaborations; and acquisitions in the artificial intelligence (AI) in healthcare market
- To benchmark players within the artificial intelligence (AI) in healthcare market using the Company Evaluation Matrix framework, which analyzes market players on various parameters within the broad categories of business strategy, market share, and product offering.
Available customizations:
With the given market data, MarketsandMarkets offers customizations as per your company’s specific needs. The following customization options are available for the report:
Company Information
- Detailed analysis and profiling of additional market players (up to 5)
Geographic Analysis
- Further breakdown of the Rest of Europe artificial intelligence (AI) in healthcare market into Denmark, Norway, and others
- Further breakdown of the Rest of Asia Pacific artificial intelligence (AI) in healthcare market into Vietnam, New Zealand, Australia, South Korea, and others
Get the Full Artificial Intelligence (AI) in Healthcare Market Report
Full forecast, segment splits, and company analysis for all Artificial Intelligence (AI) in Healthcare Market.
- US Artificial Intelligence (AI) in Healthcare Market
- Canada Artificial Intelligence (AI) in Healthcare Market
- Germany Artificial Intelligence (AI) in Healthcare Market
- UK Artificial Intelligence (AI) in Healthcare Market
- France Artificial Intelligence (AI) in Healthcare Market
- Italy Artificial Intelligence (AI) in Healthcare Market
- Spain Artificial Intelligence (AI) in Healthcare Market
- China Artificial Intelligence (AI) in Healthcare Market
- Japan Artificial Intelligence (AI) in Healthcare Market
- India Artificial Intelligence (AI) in Healthcare Market
- Brazil Artificial Intelligence (AI) in Healthcare Market
- Mexico Artificial Intelligence (AI) in Healthcare Market
Need a Tailored Report?
Customize this report to your needs
Get 10% FREE Customization
Customize This Report